chrisvoncsefalvay/vaers-outcomes huggingface dataset:
VACCINE OUT OF THE VIAL ONE DAY BEFORE THE ADMINISTRATION AND THEN STORED IT IN THE REFRIGERATOR; POOR QUALITY VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned multiple patients. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 28-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 28-MAY-2021, the subject experienced vaccine out of the vial one day before the administration and then stored it in the refrigerator. On 28-MAY-2021, the subject experienced poor quality vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine out of the vial one day before the administration and then stored it in the refrigerator and poor quality vaccine administered was not reported. This report was non-serious.
8 days after my shot, I woke up with my arm being swollen, red, itchy and sore. I also noticed 3 itchy bumps/welts on upper right thigh (which I  attributed to insect bites) but they have gradually increased to both thighs, over the knees, on tops of feet, tops of hands, and on my right wrist.
A report had been received from Health Professional via medical representative concerning a male child patient. The patient's medical history included epistaxis. Concurrent disease and concurrent medication were not reported. It was reported that a patient had bad nosebleed approximately one hour after being given FLUMIST QUADRIVALENT (intranasal), 0.2 millilitres, unknown frequency. Action taken with FLUMIST QUADRIVALENT was unknown. The outcome of the event of bloody nose was unknown. The reporter considered the event of bloody nose to be non serious.
18-20 hours following the vaccination, after going to bed, I started experiencing chills, followed by intense, all-over body aches. This was accompanied by either bizarre dreams or hallucinations during the night. When I awoke in the morning I was very unrested and very unstable. My morning coffee did not taste appealing. By 30 hours after the vaccination I had returned to feeling better, albeit with a mildly sore injection site, and was able to return to normal activity. No treatment was sought.  No further issues presented themselves.
FIrst dose was administered on 05Jan2021; Fever; Sore arm around injection site; swollen and sore lymph nodes: neck and arm of of injection; swollen and sore lymph nodes: neck and arm of of injection; Indigestion; This is a spontaneous report from a contactable 28-year-old female consumer reporting for herself   A 28 years old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: El3300) on 22Jan2021 at 08:15 at single dose via an unspecified route of administration on right arm for COVID-19 immunization. Relevant medical history included Shellfish allergy and allergy to doxicicline. The patient received first dose of vaccine on 05Jan2021 at 03:00 PM on right arm, lot_number=Ej1685.  On 22Jan2021 at 18:00 the patient experienced fever, sore arm around injection site, swollen and sore lymph nodes: neck and arm of injection Indigestion (as reported). At the time of the reporting the patient had not yet recovered from reported events.
When pt arrived for #3 GARDASIL mom ask it if was normal the patient had a migraine (already had hx of occ migraines) w/numbness on hands/arms (lasted for hrs) day of shot/vaccine - has had increased frequency of migraines - numbness resolved still having H/A.
First day, loss taste (bland; resolved voer 1 week), heache back of head/skull base not controlled with excedrin (which alwasy helped ha in past), hyperactive insomnia first night. R ear pain. Later October, severe neurological deficits: L face numb, severe pain behind L eye socket w/blurryh vision. L face droop, and groin spasms/pain, bruising in abdomen/calves/thighs. Findings on 11/21 office visit include decrease sensation L face/forehead, hyperflex r knee, decrease sensation LLE lateral, R lat gaze nystagmus, still dealing w/ severe fatigue and L side skull numb/heavy/headache/groin pain w/o help fro excedrin
experienced jitteriness and rapid heartbeat. We kept her seated, monitored her and gave her water to drink. Monitored for 30 minutes. We offered to call 911 and she declined, saying she did not feel that bad. We monitored with someone with her one on one for 30 minutes. She was fine and cheerful when she left the pharmacy.
Headache and fatigue six hours after continuing to next day, then severe headache, nausea, vomitting, unable to keep even water down, lasting for over 12 hours, lost sense of taste for 24 hours, and developed rash behind right ear.
Cellulitis, redness, tenderness, induration. Antibiotics x 10D orally. Pt may received rest of Anthrax doses also prednisone 60mg 3//40/bd.
The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 11-APR-2021 13:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-APR-2021, the subject experienced achiness. On 11-APR-2021, the subject experienced fever. On 11-APR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 100 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, headache, and achiness. This report was non-serious. This report was associated with product quality complaint: 90000175989. The suspected product quality complaint has been confirmed to be voided(did not meet PQC criteria) based on the PQC evaluation/investigation performed.
Sudden intense pain in neck, chest, head area (so intense that I had a root canal tooth removed hoping this was the cause, although my dentist could not see anything, and it didn't help).  Pain and tingling in my arms. In addition a few weeks into it pain in my inner thighs and strange bruising patterns down my thighs, and tingling legs. severe  bladder pain, and constant feeling  that I need to go to bathroom (bladder infection was ruled out). Pain is usually much worse at night. Sleep has become very difficult. Throat issues to a degree that I constantly have to clear my throat before I'm able to talk  Massages, acupuncture helps, also tried PT for jaw area. IV immunity drips (does not help) Saw 2 general practitioners, one osteopath, one gynecologist, and dentist.  There are days which are better and then days where I can't work and need to cancel my patients.
administered with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) in a 39-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 013H21B) for COVID-19 vaccination.     It was reported that the patient did not have any allergies to medication, food and other products, and also patient did not have any acute illness at the time of vaccination and up to one month before. Patient did not have any chronic illness or long standing health conditions.    On 30-Mar-2022 at 11:06 AM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 30-Mar-2022 at 11:06 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) outcome was unknown.      For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products were not provided.  It was reported that the patient did not experience similar event in the past. The potential cause for the event to occur was expired moderna vaccine. The event did not cause the patient to seek medical care. It was reported that the vial was first stored in the refrigerator on 01-Mar-2022. It was reported that vial did not undergo any temperature excursion.  Treatment medications were not reported.
The adverse conditions lasted 24 hours, 1 day after the vaccination.  The effects were same as Covid; severe headache, dizziness, no appetite, extreme fatigue, and no cough.   The symptoms were as severe as Covid, which I had in early December 2021
No Adverse Event, no local reaction or systemic. 11/05/09 noted employee over the age of 49. Health Department and Medical Director notified. No action taken.
This case was reported by a consumer via call center representative and described the occurrence of air in intestines in a 59-year-old male patient who received SHINGRIX. On 5th February 2018 19:30, the patient received the 1st dose of SHINGRIX .5 ml. On 5th February 2018, less than a day after receiving SHINGRIX, the patient experienced myalgia and fatigue. On 6th February 2018, the patient experienced injection site pain. On 9th February 2018, the patient experienced air in intestines and gastrointestinal pain. In February 2018, the patient experienced shivering. In February 2018, the outcome of the injection site pain, shivering, myalgia and fatigue were recovered/resolved. On an unknown date, the outcome of the air in intestines and gastrointestinal pain were not recovered/not resolved. It was unknown if the reporter considered the air in intestines, gastrointestinal pain, injection site pain, shivering, myalgia and fatigue to be related to SHINGRIX. Additional information was reported as follows: The patient received SHINGRIX in the left arm. The patient received vaccine at 19:30 hours on 5th February 2018. On 9th February 2018, 4 days after receiving SHINGRIX, the patient experienced intestinal gas and gastrointestinal pain. On 6th February 2018, a day after the vaccination, the patient experienced injection site pain that and it was lasted for 4 days. On 6th February 2018, 9 hours 30 minutes, after receiving SHINGRIX, the patient experienced shivering that started at approximately 5:00 am and lasted for 24 hours after the vaccination. On 5th February 2018, less than a day, after receiving SHINGRIX, the patient experienced myalgia, and fatigue which were worse for the first 24 hours after the vaccination and lessened over the next two days. The patient felt so bad the next day after the injection that he did not go into work until 11:30am. The myalgia and fatigue resolved after 3 days. The patient had denied permission to contact their physician. Reporter did not have the lot number and expiration date for the product.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 16-MAY-2017, the patient was vaccinated with ZOSTAVAX, lot number M037016, expiration date: 22-NOV-2017 (dose was not reported) subcutaneously "in the back of the arm" for prophylaxis. Other suspect therapies included sterile diluent (STERILE DILUENT) (lot number and expiration date were not provided). The pharmacist reported that the patient may have received a second dose of ZOSTAVAX. After the pharmacist administered the ZOSTAVAX to the patient on 16-MAY-2017, the patient said, "I think I may have received ZOSTAVAX previously because of where you administered that dose." The pharmacist stated that the patient may have received the first dose "at least a year ago ." The patient has not reported any adverse effects. No additional information was provided. Additional information has been requested.
Was really sick for 3 days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "recovered", described as "Was really sick for 3 days".  Additional Context: The report is cross referenced to report ID: Withheld  Warm transfer from withheld with Pfizer Medical Information: Withheld. Caller was told by the CDC to contact Pfizer. She had her first Pfizer BioNTech COVID-19 Vaccine at the end of August and 10 days later she had the second dose administered. She states her sister got the basic vaccine and her husband got the vaccine and was really sick for 3 days. Her sister went religiously right after she remembers her getting very sick. She told her sister the flu shots are brought around and she read in the paper the flu shots wasn't effective. Her sister and her brother in law are both 90-year-old and have dementia problems. Her sister is the only one she has left of 7. She can't understand what you are saying anymore and her husband is in the same boat. She states this is a very sad way to live this long only for your brain to go.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Severe pain in upper left arm; red from shoulder almost to elbow. Couldn't move arm for 2 days. Arm was warm to touch. No fever. Slowly resolved over approx. 6 days.
Broke out into rash (red, bumpy and itchy) on right arm that was moving towards injection site - on the 23rd. We saw the doctor and they gave him Triamcinolone cream - 0.1% cream - twice a day and the rash is almost completely gone now. He started that on the 25th - the rash had moved over to left arm on the 25th.
About 10 hours after receiving FLUMIST she experienced nausea, vomiting, diarrhea, epigastric pain, myalgias, and chills.
PATIENT RECEIVED A THIRD DOSE OF COVID-19 VACCINE THAT SHE DID NOT NEED.  DUE LANGUAGE BARRIER AND POOR COMMUNICATION THE INCORRECT VACCINE WAS ASSESSED, AND APPLIED. HER DR WAS CONTACTED AND WAS INFORMED OF WHAT HAPPENED AND REFERED THE ER FOR OBSERVATION
This spontaneous report as received from a patient's husband refers to 82 year old female patient with high blood pressure and allergy to penicillin. Historical drugs included penicillin. In November 2015, the patient was vaccinated with a dose of ZOSTAVAX in the left arm (dose, route of administration, lot # and expiration date not reported). Concomitant therapies included unspecified "blood pressure medicine". On an unknown date in 2015 (also reported as: about a week after receiving the vaccine), the patient experienced fever and redness at the injection site. The outcome of events was not reported. The relatedness of events was not reported. The relatedness between ZOSTAVAX and the events was not assessed. Additional information is not expected as there was no consent to contact the physician.
45 minutes after receiving vaccinations the child started crying and became inconsolable then developed a fever, clamminess and vaccine site appeared red and swollen. Was seen in the ER and released.
Flushing on cheeks and lower abdomen; Burning sensation on cheeks and lower abdomen; Burning sensation on cheeks and lower abdomen; This case was reported by a pharmacist via call center representative and described the occurrence of facial flushing in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number 9DE73, expiry date unknown) for prophylaxis.   On 7th October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced facial flushing, burning sensation in face and burning sensation in abdomen. On an unknown date, the outcome of the facial flushing, burning sensation in face and burning sensation in abdomen were unknown.   It was unknown if the reporter considered the facial flushing, burning sensation in face and burning sensation in abdomen to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was complaing of a flushing, burning sensation on cheeks and lower abdomen. The patient thought it may be associated with the vaccine. The reporter consented to follow up.
High blood sugar; Her blood sugar has been going up and down.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid left, administration date 19Apr2021 12:00 (Lot number: EW0158) at the age of 65 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (ongoing), notes: It has been years, she thinks it maybe five years ago. The patient's concomitant medications were not reported. The following information was reported: BLOOD GLUCOSE INCREASED (non-serious), outcome "unknown", described as "High blood sugar"; BLOOD GLUCOSE FLUCTUATION (non-serious), outcome "unknown", described as "Her blood sugar has been going up and down.". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Other Products was reported as, No. Clinical course was reported as, patient stated she is scheduled for the second dose of the vaccine today but when she took her blood sugar it was really high. Caller would like to know if her high blood sugar reading will affect her receiving the second dose today? She does not remember when she was diagnosed with diabetes. It has been years, she thinks it maybe five years ago. Her blood sugar has been going up and down. Sometimes, her blood sugar will be good two days in a row, and then it will go back up again. She does not know a start date. Confirmed she was reporting about Pfizer covid vaccine. Reporter seriousness for High blood sugar was unspecified.  No follow-up attempts are possible. No further information is expected.
This case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 332974). A 42-year-old female patient received intramuscular injections of ADACEL (lot number C2774AA) and FLUZONE SV 2008-2009 (lot number U2744AA) on 05 November 2008. Later that day, she began experiencing itchy eyes and a persistent, productive cough. Her eyes became red and puffy, cheeks flushed, face puffy, lips swollen, and chest red, warm and itching. She later complained of a headache, fever, chills, and body aches. She took one Ibuprofen and treated the swelling with ice chips. She did not seek medical treatment. A doctor's appointment was reportedly scheduled for 06 November 2008, however no details were provided regarding this appointment. Outcome was not provided.
muscle pain, tiredness, shivering, fever, nausea, insomnia that began the evening after my injection. they have continued for two days, although they were slightly less severe last night than the night before.
The night of the injection, I woke up with a 10/10 headache,  tinnitus, and shortness of breath. I thought nothing of the shortness of breath as I am asthmatic. The next couple of days I felt completely drained, fatigued. Ten days later I have partial facial paralysis. I saw the emergency physician at the hospital who prescribed prednisone, acyclovir, over the counter eye drops, and an eye patch to wear at night.
I took the flu shot 3 years in a row and had the flu 3 years in a row; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 08-Dec-2020.  This case involves a patient of unknown demographics who reported that I took the flu shot 3 years in a row and had the flu 3 years in a row (Influenza), while the patient received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date the patient took the flu shot three years in a row. It was bad and the last time the patient had it the patient thought like going to die. The patient had not taken the shot in about 18 years and never had the flu before or since.  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
Arm pain, swelling; nighttime chills, malaise, fatigue for 1 day following shot
Arm very swollen; Redness on arm; Itchiness on arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm very swollen), ERYTHEMA (Redness on arm) and PRURITUS (Itchiness on arm) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced PERIPHERAL SWELLING (Arm very swollen), ERYTHEMA (Redness on arm) and PRURITUS (Itchiness on arm). At the time of the report, PERIPHERAL SWELLING (Arm very swollen), ERYTHEMA (Redness on arm) and PRURITUS (Itchiness on arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products included Thyroid medication for an unknown indication.Treatment medication was not provided.
Heart rate increased; Weakness; Ache; Pain in arm; Redness; Swelling arm; Dizziness; Chills; Throat tightness; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness) and PAIN (Ache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Tested positive for antibodies in November 2020. Waited 90 days before receiving the vaccine. ) in October 2020. Concurrent medical conditions included Shellfish allergy.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) at a dose of UNK dosage form. At the time of the report, PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.